Short answer. Condition 5 says compounders report serious adverse events associated with the compounded drug in people, whether or not the event is considered drug-related, and they report product-quality problems. Reports go to FDA's MedWatch program and to the relevant states [2]. As of Oct 29, 2026.

What gets reported

The policy gives examples of quality problems: bacteriological contamination, a significant chemical or physical change, or a failure to meet specifications [2]. It also says the compounder reports the products themselves, including the active ingredient and its strength per unit, the original manufacturer and that facility's identifier, and the dosage form and route [2].

The procedure for reporting events, and problems with identity, strength, purity, or quality, is supposed to be on the labeling the patient gets [2]. If you have a covered product and you cannot find that instruction, ask the pharmacy. Do not hunt for medical advice in a comment section.

What this is for

HHS says the reports give FDA and states a chance to act on emerging risks [2]. The same policy says HHS may revisit it, in whole or in part, if a safety signal or a product-quality issue appears [1][2]. Reporting is how that signal would be visible. A policy that asks for reports is not a promise that nothing will go wrong.

If you think you are having a medical emergency, use emergency care. MedWatch is a reporting program. It is not a clinic. Sommar Club does not prescribe or sell these six peptides. Nothing on this page is a reason to start one.

FAQ

Do I report only if I am sure the peptide caused it? The policy tells compounders to report serious events regardless of whether they are considered drug-related [2]. Your own next step in an emergency is medical care.

Does reporting mean the product is in a safety study? No. It is a condition of this enforcement policy [2].

Sources

1. HHS notice, FR Doc. 2026-22192, filed Oct 28, 2026. https://public-inspection.federalregister.gov/2026-22192.pdf

2. HHS policy, condition 5. MedWatch: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program

Education only. Not medical or legal advice. As of Oct 29, 2026.